Citadel Advisors
BHC icon

Citadel Advisors’s Bausch Health BHC Stock Holding History

Citadel Advisors’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$852K Buy
157,700
+1,500
+1% +$8.98K ﹤0.01% 8028
2025
Q4 		$1.09M Sell
156,200
-228,200
-59% -$1.5M ﹤0.01% 7209
2025
Q3 		$2.48M Sell
384,400
-18,200
-5% -$124K ﹤0.01% 5644
2025
Q2 		$2.68M Sell
402,600
-130,400
-24% -$670K ﹤0.01% 5167
2025
Q1 		$3.45M Sell
533,000
-354,000
-40% -$2.54M ﹤0.01% 4523
2024
Q4 		$7.15M Sell
887,000
-839,100
-49% -$6.92M ﹤0.01% 3414
2024
Q3 		$14.1M Sell
1,726,100
-176,300
-9% -$1.16M ﹤0.01% 2458
2024
Q2 		$13.3M Sell
1,902,400
-1,701,500
-47% -$12.9M ﹤0.01% 2446
2024
Q1 		$38.2M Buy
3,603,900
+257,900
+8% +$2.26M 0.01% 1430
2023
Q4 		$26.8M Buy
3,346,000
+1,079,600
+48% +$7.86M 0.01% 1726
2023
Q3 		$18.6M Buy
2,266,400
+279,800
+14% +$2.41M ﹤0.01% 1940
2023
Q2 		$15.9M Buy
1,986,600
+956,100
+93% +$7.05M ﹤0.01% 2116
2023
Q1 		$8.35M Sell
1,030,500
-87,000
-8% -$699K ﹤0.01% 3044
2022
Q4 		$7.02M Sell
1,117,500
-619,400
-36% -$4.33M ﹤0.01% 3326
2022
Q3 		$12M Buy
1,736,900
+512,400
+42% +$3.56M ﹤0.01% 2505
2022
Q2 		$10.2M Sell
1,224,500
-74,300
-6% -$1.04M ﹤0.01% 2658
2022
Q1 		$29.7M Buy
1,298,800
+440,200
+51% +$10.8M 0.01% 1566
2021
Q4 		$23.7M Sell
858,600
-91,500
-10% -$2.45M ﹤0.01% 1836
2021
Q3 		$26.5M Sell
950,100
-271,500
-22% -$7.7M 0.01% 1685
2021
Q2 		$35.8M Buy
1,221,600
+377,600
+45% +$11.4M 0.01% 1426
2021
Q1 		$26.8M Sell
844,000
-73,700
-8% -$2.16M 0.01% 1626
2020
Q4 		$19.1M Buy
917,700
+83,100
+10% +$1.55M 0.01% 1854
2020
Q3 		$13M Buy
834,600
+19,400
+2% +$334K ﹤0.01% 1992
2020
Q2 		$14.9M Sell
815,200
-17,800
-2% -$314K 0.01% 1781
2020
Q1 		$12.9M Sell
833,000
-214,500
-20% -$5.17M 0.01% 1618
2019
Q4 		$31.3M Buy
1,047,500
+144,900
+16% +$3.77M 0.01% 1086
2019
Q3 		$19.7M Sell
902,600
-252,700
-22% -$5.78M 0.01% 1485
2019
Q2 		$29.1M Sell
1,155,300
-73,600
-6% -$1.75M 0.01% 1095
2019
Q1 		$30.4M Sell
1,228,900
-1,232,000
-50% -$29.4M 0.02% 1015
2018
Q4 		$45.5M Buy
2,460,900
+209,300
+9% +$4.98M 0.02% 678
2018
Q3 		$57.8M Buy
2,251,600
+722,700
+47% +$16.5M 0.03% 676
2018
Q2 		$35.5M Sell
1,528,900
-506,500
-25% -$10.5M 0.02% 895
2018
Q1 		$32.4M Sell
2,035,400
-1,209,900
-37% -$22.5M 0.02% 804
2017
Q4 		$67.4M Buy
3,245,300
+704,900
+28% +$11.2M 0.04% 481
2017
Q3 		$36.4M Sell
2,540,400
-366,800
-13% -$5.55M 0.03% 716
2017
Q2 		$50.3M Buy
2,907,200
+1,920,400
+195% +$23M 0.04% 490
2017
Q1 		$10.9M Sell
986,800
-570,300
-37% -$7.85M 0.01% 1377
2016
Q4 		$22.6M Sell
1,557,100
-301,500
-16% -$5.53M 0.02% 787
2016
Q3 		$45.6M Buy
1,858,600
+62,900
+4% +$1.63M 0.05% 427
2016
Q2 		$36.2M Buy
1,795,700
+297,900
+20% +$8.43M 0.04% 474
2016
Q1 		$39.4M Buy
1,497,800
+794,000
+113% +$58.7M 0.05% 396
2015
Q4 		$71.5M Buy
703,800
+374,400
+114% +$42.1M 0.08% 274
2015
Q3 		$58.8M Buy
329,400
+171,100
+108% +$39.9M 0.06% 367
2015
Q2 		$35.2M Sell
158,300
-2,000
-1% -$443K 0.03% 666
2015
Q1 		$31.8M Sell
160,300
-7,200
-4% -$1.28M 0.03% 714
2014
Q4 		$24M Sell
167,500
-14,500
-8% -$1.95M 0.02% 823
2014
Q3 		$23.9M Sell
182,000
-48,300
-21% -$5.76M 0.03% 810
2014
Q2 		$29M Buy
230,300
+70,600
+44% +$9.01M 0.03% 621
2014
Q1 		$21.1M Buy
159,700
+6,400
+4% +$875K 0.02% 794
2013
Q4 		$18M Buy
153,300
+11,100
+8% +$1.22M 0.02% 860
2013
Q3 		$14.8M Buy
142,200
+11,200
+9% +$1.09M 0.02% 873
2013
Q2 		$11.3M Buy
+131,000
New +$10.3M 0.02% 994

Other funds holding BHC

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citadel Advisors's BHC Position: Q1 2026 in Review

Citadel Advisors reduced its Bausch Health (BHC) stake by 39% in Q1 2026, selling an estimated $3.44M and leaving 912,171 shares worth $4.93M. The position accounts for ﹤0.01% of the portfolio, ranked #4363.

Citadel Advisors first reported a position in BHC in Q2 2013 and has held it in 52 quarters since. The position peaked at $142M in Q4 2014. 227 funds tracked by Wall St. Rank hold BHC as of Q1 2026.

  • Citadel Advisors held 912,171 shares of Bausch Health worth $4.93M as of Q1 2026.
  • Citadel Advisors sold 575,124 Bausch Health shares in Q1 2026, an estimated $3.44M.
  • Bausch Health made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4363 holding.
  • Citadel Advisors first reported a position in Bausch Health in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Bausch Health position peaked at $142M in Q4 2014.
  • 227 funds tracked by Wall St. Rank held Bausch Health as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.